View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
January 26, 2018updated 08 Sep 2022 7:52am

Deals this week: Kingstronbio, Ad Me Tech, Cardiovascular Systems

Chinese company Kingstronbio (Changshu) Co Ltd has raised $19.5m through a Series B funding round led by Salubris Biotherapeutics Inc (SalubrisBio).

Chinese company Kingstronbio (Changshu) Co Ltd has raised $19.5m through a Series B funding round led by Salubris Biotherapeutics Inc (SalubrisBio).

Free Report
img

What is driving M&A activity in the MedTech space?

The COVID-19 pandemic has left an indelible mark on the MedTech landscape. Changes in how healthcare is delivered, and new treatment modalities, are creating opportunities and challenges for both new and traditional players. As companies sought out opportunities during the pandemic-driven downturn, the number and value of mergers and acquisition deals in the MedTech space increased. Companies worked to reposition themselves in the newly aligned healthcare world, but with further economic turmoil expected: will these trends be repeated? And what tech areas should firms be looking to expand their capabilities into? GlobalData’s report, “Themes driving M&A activity in the Medical Devices Sector, Q1 2022,” draws upon GlobalData’s extensive MedTech deals databases, highlighting major trends and hot themes in M&A activity. This report will assist you in:
  • Understanding value and volume trends in M&A from Q1 2018 to Q1 2022
  • Understanding regional trends in M&A activity
  • Understanding which medical device sectors are leading M&A activity, and which are lagging
  • Understanding the leading tech trends in Q1 2022 M&A activity
  • Knowing the key deals that occurred during Q1 2022
Download the full report to understand what to expect and how to align your business for success.
by GlobalData
Enter your details here to receive your free Report.

Ad Me Tech Co Ltd plans to raise CNY‎10m ($0.089m) through the private placement of 64,500 new shares priced at CNY155 ($1.39) a share.

The Japanese company plans to use the funds for the production of AMTC 300 B and self-heating needles for the National Cancer Institute of Ukraine and other hospitals.

Cardiovascular Systems Inc will distribute OrbusNeich’s balloon products in the US.

Based in the US, Cardiovascular Systems is a medical device company, while OrbusNeich is a medical device supplier based in China.

The collaboration enables the two companies to expand their product portfolio.

PolyNovo Ltd has signed an agreement with Establishment Labs SA to develop medical devices for breast aesthetics and reconstruction.

“The company will grant underwriters an option to purchase additional shares at the same offer price within 45 days.”

PolyNovo will develop the polymers for the devices as part of the agreement, while Establishment Labs will carry out animal and clinical trial programmes.

Based in Australia, PolyNovo is a medical device company, while Establishment Labs is a silicone-filled breast implants designer based in Costa Rica.

PAVmed Inc plans to raise $75m through a public offering of shares of its common stock.

The company will grant underwriters an option to purchase additional shares at the same offer price within 45 days.

The US-based company plans to use the funds for working capital and other corporate purposes.

US-based GI Dynamics Inc plans to raise A$2.05m ($1.6m) through the private placement of 28.5 million CHESS Depositary Interests (CDIs) priced at A$0.03 ($1.6m) a CDI.

The proceeds are intended to be used for the development of EndoBarrier and for working capital purposes.

Related Companies

Free Report
img

What is driving M&A activity in the MedTech space?

The COVID-19 pandemic has left an indelible mark on the MedTech landscape. Changes in how healthcare is delivered, and new treatment modalities, are creating opportunities and challenges for both new and traditional players. As companies sought out opportunities during the pandemic-driven downturn, the number and value of mergers and acquisition deals in the MedTech space increased. Companies worked to reposition themselves in the newly aligned healthcare world, but with further economic turmoil expected: will these trends be repeated? And what tech areas should firms be looking to expand their capabilities into? GlobalData’s report, “Themes driving M&A activity in the Medical Devices Sector, Q1 2022,” draws upon GlobalData’s extensive MedTech deals databases, highlighting major trends and hot themes in M&A activity. This report will assist you in:
  • Understanding value and volume trends in M&A from Q1 2018 to Q1 2022
  • Understanding regional trends in M&A activity
  • Understanding which medical device sectors are leading M&A activity, and which are lagging
  • Understanding the leading tech trends in Q1 2022 M&A activity
  • Knowing the key deals that occurred during Q1 2022
Download the full report to understand what to expect and how to align your business for success.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network